CyberSecurity Breakthrough Award - Cobwebs Technologies
Cobwebs Technologies Named 'Threat Intelligence Platform of the Year' in 2021 CyberSecurity Breakthrough Awards Program
September 30, 2021 01:00 ET | Cobwebs Technologies
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Cobwebs Technologies, an industry-leading provider of AI-driven automated digital risk protection platform, today announced that it has been named the...
Anpac Bio LOGO.jpg
AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO
August 17, 2021 07:30 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION
May 19, 2021 08:30 ET | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, May 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the...
AMR Logo.png
Global PPE detection market to reach $1.97 billion by 2027: Allied Market Research
April 20, 2021 09:30 ET | Allied Market Research
Portland,OR, April 20, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global PPE detection market generated $31.28 million in 2019, and is projected to...
FACT Inc LOGO.jpg
FACT Inc. (OTC: FCTI) Expanding into Burgeoning NFT Market
April 08, 2021 08:30 ET | FACT, Inc.
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — FACT Inc. (OTC: FCTI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
February 18, 2021 08:30 ET | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the...
patriot_one_for_pr3.jpg
Patriot One Unveils New PATSCAN Mobile Concept at International Association of Chiefs of Police (IACP) Conference
October 28, 2019 08:00 ET | Patriot One Technologies Inc
TORONTO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Awarded NIH Ph2A Grant for Cerebral Amyloid Angiopathy
September 23, 2019 07:00 ET | Amydis, Inc.
SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary drugs to detect, monitor, and screen for amyloid-related diseases,...
patriot_one_for_pr3.jpg
Patriot One Signs Substantial Reseller Agreement for Deployment of PATSCAN™ VRS Solution with Cramer Security & Investigations, Inc.
May 23, 2019 08:00 ET | Patriot One Technologies Inc
TORONTO, May 23, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc.(TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One”, “Patriot One Technologies” or the “Company”), is pleased to announce...
Amydis_Logo_Horiz_RGB@2x.png
UPDATE - Amydis Awarded Prion Disease Grant from NIH
September 26, 2018 14:05 ET | Amydis, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative technology to detect amyloid-related diseases,...